Although observational data suggest that non-overdose paracetamol ingestion may cause liver failure in a very small proportion of people and ALT rises of uncertain clinical significance occur in some patients treated with paracetamol in RCTs, there is no good evidence that therapeutic doses of paracetamol present a greater risk of toxicity in any group covered by this review [24–26]. This evidence concerns the gene GPT and Hepatic failure.